{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34100886",
  "DateCompleted": {
    "Year": "2021",
    "Month": "06",
    "Day": "14"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "06",
    "Day": "14"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1001/jama.2021.8165"
    ],
    "Journal": {
      "ISSN": "1538-3598",
      "JournalIssue": {
        "Volume": "325",
        "Issue": "22",
        "PubDate": {
          "Year": "2021",
          "Month": "Jun",
          "Day": "08"
        }
      },
      "Title": "JAMA",
      "ISOAbbreviation": "JAMA"
    },
    "ArticleTitle": "\"Nanotraps\" Designed to Capture and Clear SARS-CoV-2.",
    "Pagination": {
      "StartPage": "2243",
      "MedlinePgn": "2243"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Abbasi",
        "ForeName": "Jennifer",
        "Initials": "J"
      }
    ],
    "PublicationTypeList": [
      "News"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "JAMA",
    "NlmUniqueID": "7501160",
    "ISSNLinking": "0098-7484"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Neutralizing"
    },
    {
      "RegistryNumber": "EC 3.4.17.23",
      "NameOfSubstance": "Angiotensin-Converting Enzyme 2"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Angiotensin-Converting Enzyme 2"
    },
    {
      "QualifierName": [
        "physiology",
        "therapeutic use"
      ],
      "DescriptorName": "Antibodies, Neutralizing"
    },
    {
      "QualifierName": [
        "therapy"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Nanoparticles"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Nanotechnology"
    },
    {
      "QualifierName": [
        "drug effects",
        "immunology"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ]
}